MON-287 Expression of Programmed Death-Ligand 1 (PD-L1) in Human Pituitary Neuroendocrine Tumor

Introduction Some Pituitary NeuroEndocrine Tumors (PitNET) present an aggressive evolution and are resistant to standard management. Immunotherapy have shown durable efficacy in a variety of malignancies. The aim of this study was to explore the programmed death-ligand 1 (PD-L1) expression in varied...

Descripción completa

Detalles Bibliográficos
Autores principales: Suteau, Valentine, Collin, Alexandre, Menei, Philippe, Rodien, Patrice, Rousselet, Marie-Christine, Briet, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207472/
http://dx.doi.org/10.1210/jendso/bvaa046.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207472/
http://dx.doi.org/10.1210/jendso/bvaa046.113

Ejemplares similares